Literature DB >> 23430608

The authors' reply to Gow et al.: "the state of health economic research in South Africa".

Paul Gavaza, Karen L Rascati, Abiola O Oladapo, Star Khoza.   

Abstract

Mesh：

Year:  2013        PMID： 23430608     DOI： 10.1007/s40273-013-0027-8

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  6 in total

1.  The impact of reduced drug prices on the cost-effectiveness of HAART in South Africa.

Authors:  Nicoli Nattrass; Nathan Geffen
Journal:  Afr J AIDS Res       Date:  2005-05       Impact factor: 1.300

Review 2.  The state of health economic research in South Africa: a systematic review.

Authors:  Paul Gavaza; Karen L Rascati; Abiola O Oladapo; Star Khoza
Journal:  Pharmacoeconomics       Date:  2012-10-01       Impact factor: 4.981

3.  The state of health economic research in South Africa.

Authors:  Jeff Gow; Michael Strauss; Alan Whiteside
Journal:  Pharmacoeconomics       Date:  2013-03       Impact factor: 4.981

4.  South Africa's "rollout" of highly active antiretroviral therapy: a critical assessment.

Authors:  Nicoli Nattrass
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-15       Impact factor: 3.731

5.  Modelling the relationship between antiretroviral treatment and HIV prevention: limitations of the Spectrum AIDS Impact Model in a changing policy environment.

Authors:  Nicoli Nattrass
Journal:  Afr J AIDS Res       Date:  2007-08       Impact factor: 1.300

6.  Social grants, welfare, and the incentive to trade-off health for income among individuals on HAART in South Africa.

Authors:  Atheendar S Venkataramani; Brendan Maughan-Brown; Nicoli Nattrass; Jennifer Prah Ruger
Journal:  AIDS Behav       Date:  2010-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.